Skeletal Muscle · 2011 · 40 citations · 113 references
MedicineGeneticsMolecular BiologyMedical GeneticsMolecular DiagnosticsMolecular PathologyImmunohistochemistryMuscle DisordersMuscle PathologyMuscular DystrophyProtein AnalysisProtein CharacterizationGenetic Testing For MyopathyImmunohistochemistry In Muscle DiseaseMolecular Genetic DiagnosisMuscle Biopsy InterpretationMuscle DamageMuscle HistochemistryMuscle Weakness ProgressionWestern Blot Analysis
Muscular dystrophies are a large heterogeneous group of inherited diseases that cause progressive muscle weakness and permanent muscle damage. Very few muscular dystrophies show sufficient specific clinical features to allow a definite diagnosis. Because of the currently limited capacity to screen for numerous genes simultaneously, muscle biopsy is a time and cost-effective test for many of these disorders. Protein analysis interpreted in correlation with the clinical phenotype is a useful way of directing genetic testing in many types of muscular dystrophies. Immunohistochemistry and western blot are complementary techniques used to gather quantitative and qualitative information on the expression of proteins involved in this group of diseases. Immunoanalysis has a major diagnostic application mostly in recessive conditions where the absence of labelling for a particular protein is likely to indicate a defect in that gene. However, abnormalities in protein expression can vary from absence to very subtle reduction. It is good practice to test muscle biopsies with antibodies for several proteins simultaneously and to interpret the results in context. Indeed, there is a degree of direct or functional association between many of these proteins that is reflected by the presence of specific secondary abnormalities that are of value, especially when the diagnosis is not straightforward.
113
Membrane organization of the dystrophin-glycoprotein complex
James M. Ervasti, Kevin P. Campbell · Cell · 1991 · 1.3K citations
Defective membrane repair in dysferlin-deficient muscular dystrophy
Dimple Bansal, Katsuya Miyake, Steven S. Vogel et al. · Nature · 2003 · 1K citations
Medicine, Cell Biology, Genetics +13
Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A
Isabelle Richard, Odile Broux, Valéerie Allamand et al. · Cell · 1995 · 997 citations · Full text